marek health bpc-157 – Mark Hyman, MD BPC-157 - LeadWest Medical
Description
Stable 30-60 days
This warning letter, combined with the broader regulatory environment around GLP-1 compounding, signals that the FDA intends to hold compounding pharmacies accountable (particularly those producing high-profile drug products where patient safety concerns are most visible
accessed 2026-05-15) PBS NewsHour FDA to weigh easing limits on unproven peptides (published 2026-04-16
The aorta can also be inflamed leading to chest pain and this may lead to problems with the aortic heart valve as well
